"The GLP-1 shortage challenges are exacerbated by a lack of accurate, up-to-date, and accessible GLP-1 supply information
Innovation in 2025 isn't just about outcomes - it's about process efficiency, and Sprout Health delivers both
We are committed to making health access easy by accepting major insurance plans and offering semaglutide telehealth to kick off your journey from your own home
Superior weight loss with semaglutide 2.4 mg compared with placebo as adjunct to intensive behavioral therapy in adults with obesity: The STEP 3 randomized clinical trial
As the medication gradually reaches its steady state, many individuals experience a significant reduction in hunger, allowing them to make healthier food choices and control portion sizes
-20C, 1 month (sealed storage, away from moisture) Publications (45) Journal Impact Factor Most Recent J Adv Res A novel GIPR/GLP-1R dual agonist improves systemic metabolism through differentially regulating inflammation and lipid metabolism in obesity